Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
NEW YORK (Reuters Health) – By binding dietary oxalate, calcium supplements or calcium-containing foods may be useful in the management of hyperoxaluria, new research suggests. Hyperoxaluria is present…
NEW YORK (Reuters Health) – Among relatively healthy patients on hemodialysis, normalization of hemoglobin levels with epoetin-alfa, rather than partial correction, improves energy levels and reduces fatigue, investigators…
NEW YORK (Reuters Health) – Initial low-dose gentamicin given as part of the treatment for Staphylococcus aureus bacteremia and endocarditis can cause kidney dysfunction and should not be…
NEW YORK (Reuters Health) – Use of a high cut-off dialyzer can help patients with acute renal failure secondary to multiple myeloma become dialysis free, the results of…
Mitchell H. Rosner, MD, Associate Professor of Medicine, University of Virginia Health System, discusses the prevalent condition of chronic hyponatremia and the latest diagnostic and treatment options for…
Mitchell H. Rosner, MD, Associate Professor of Medicine, University of Virginia Health System, discusses the prevalent condition of hyponatremia in athletes and prevention strategies. References and Resources Moritz…
Mitchell H. Rosner, MD, Associate Professor of Medicine, University of Virginia Health System, discusses the epidemic of end-stage renal disease and the management options for the 450,000 patients…
Mitchell H. Rosner, MD, Associate Professor of Medicine, University of Virginia Health System, discusses the use of urinary biomarkers such as KIM-1and NGAL, to diagnose acute kidney injury…
NEW YORK (Reuters Health) – Lower serum levels of creatinine are associated with increased risk of type 2 diabetes, according to a brief report in the March issue…
NEW YORK (Reuters Health) – Rituximab appears to be of benefit to some patients with severe proliferative or membranous lupus nephritis, according to a small French study published…